跳至主要内容
临床试验/NCT01174628
NCT01174628Unknown不适用

The ELOPE Study: Prospective Evaluation of Long-term Outcomes After Pulmonary Embolism

Sir Mortimer B. Davis - Jewish General Hospital5 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2010年6月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
150
试验地点
5
主要终点
Exercise Limitation

研究概览

简要总结

The purpose of this study is to evaluate the long-term impact of Pulmonary Embolism (PE) on heart and lung function, quality of life, ability to work, symptoms of breathlessness and functional status of patients one year after their initial diagnosis and treatment for PE

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • First episode of acute symptomatic PE that was objectively diagnosed* within last 10 days
  • Treated with anticoagulants
  • ≥ 18 years old
  • PE will be diagnosed if there is a high probability V/Q scan (as per PIOPED Study criteria 66), an intraluminal filling defect in segmental or larger vessels on CTPA or a constant intraluminal filling defect or abrupt cut-off of vessels greater than 2.5 mm diameter on pulmonary angiography 8,
  • Patients with non-definitive test results (e.g. low or intermediate probability V/Q scan, subsegmental PE on CTPA (~5% of PE patients 12) will not be included in order to have a strictly defined population of patients with definite PE.

排除标准

  • Contraindication or unable to perform CPET or 6MWT (amputated or paralyzed limb(s), severe lower extremity arthritis, preexisting cardiopulmonary condition precluding exercise including unstable angina or myocardial infarction in last 6 weeks, uncontrolled hypertension, serious cardiac dysrhythmia on resting EKG [severe bradycardia or tachycardia, sick sinus syndrome or multifocal premature ventricular contractions] and syncope)
  • Contraindication to CTPA (allergy to iodinated contrast, CrCl or eGFR < 30 ml/min)
  • Severe comorbidity (congestive heart failure [LVEF < 35%], severe COPD or restrictive lung disease [FEV1<50%, chronic need for oxygen therapy])
  • Previous DVT (as ~40% of patients with proximal DVT have asymptomatic PE on lung imaging 67)
  • Life expectancy < 1 year (e.g. active or terminal cancer, end-stage cardiac or respiratory disease).
  • Pregnancy or lactation
  • Unable to read questionnaire in English or French
  • Unable to return to study centre for required follow-up visits
  • Unable or unwilling to provide written informed consent

结局指标

主要结局

Exercise Limitation

时间窗: 12 months

Exercise limitation will be assessed by VO2 max (% predicted) on cardiopulmonary exercise testing (CPET)

次要结局

  • Quality of Life(12 months)
  • Respiratory Disease-Specific Measures(12 months)

研究者

发起方
Sir Mortimer B. Davis - Jewish General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Susan Kahn

M.D., M.Sc.

Sir Mortimer B. Davis - Jewish General Hospital

研究点 (5)

Loading locations...

相似试验